Take the Next Step

Enter your email address to stay informed with the latest information about portfolio monitoring

Magnifying Glass

Check for Losses!

Kaplan Fox has the experience, skills, and resources to aggressively pursue our clients' rights on issues of securities fraud.

Contact Us to Start

Current Case Investigations

The Walt Disney Company

May 24, 2023 – Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of The Walt Disney Company (“Disney” or the “Company”) common stock (NYSE: DIS) between December 10, 2020 and November 8, 2022, inclusive (the “Class Period”). Click Here to Join Investigation.

Integra LifeSciences Holdings Corporation

May 23, 2023 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims on behalf of investors who purchased Integra LifeSciences Holdings Corporation (Nasdaq: IART) securities. Click Here to Join Investigation.

Intercept Pharmaceuticals, Inc.

May 22, 2023 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims on behalf of investors who purchased Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) securities. Click Here to Join Investigation.

Beyond Meat, Inc.

May 17, 2023 – Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of Beyond Meat, Inc. (“Beyond Meat” or the “Company”) common stock (NASDAQ: BYND) between May 5, 2020 and October 13, 2022, inclusive (the “Class Period”). Click Here to Join Investigation.

ImmunityBio, Inc.

May 11, 2023 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX). Click Here to Join Investigation.

Icahn Enterprises L.P.

May 11, 2023 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Icahn Enterprises L.P. (“Icahn Enterprises” or the “Company”) (NASDAQ: IEP). Click Here to Join Investigation.

Load More

Settlement Filing Deadlines

Company Ticker Class Period Deadline Administrator
Xencor, Inc. XNCR On behalf of all former holders of Xencor, Inc.'s (the "Company") Series A-E preferred stock whose shares were converted to A-1 stock in the Recapitalization. 5/13/17 Strategic Claims Services  
Molycorp, Inc. MCP 2/21/2012 - 10/15/2013 5/18/17 Angeion Group  
Health Enhancement Products, Inc. (N/K/A Zivo Bioscience, Inc.) HEPI 10/31/2003 - 5/31/2004 5/18/17 Rust Consulting, Inc.  
Barclays Bank PLC (Electronic Foreign Exchange Trading - BARX) n/a 6/1/2008 - 4/21/2016 5/19/17 Garden City Group  
EZCORP, Inc. EZPW 4/19/2012 - 10/6/2014 5/19/17 Garden City Group  
King Digital Entertainment plc KING 3/26/2014 - 9/22/2014 5/23/17 Gilardi & Co.  
Load More